Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3060](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3060) → MJL — Eia, Blastomyces Dermatitidis

# MJL · Eia, Blastomyces Dermatitidis

_Microbiology · 21 CFR 866.3060 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MJL

## Overview

- **Product Code:** MJL
- **Device Name:** Eia, Blastomyces Dermatitidis
- **Regulation:** [21 CFR 866.3060](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3060)
- **Device Class:** 2
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Blastomyces dermatitidis serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to Blastomyces determatitidis in serum. The identification aids in the diagnosis of blastomycosis caused by the fungus Blastomyces dermatitidis. Blastomycosis is a chronic granulomatous (tumor-like) disease, which may be limited to the skin or lung or may be widely disseminated in the body resulting in lesions of the bones, liver, spleen, and kidneys.

## Classification Rationale

Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K923859](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MJL/K923859.md) | PREMIER BLASTOMYCES | Meridian Diagnostics, Inc. | Oct 5, 1992 | SESE |
| [K840201](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MJL/K840201.md) | EPIDURAL CATHETER TRAY | Aries Medical, Inc. | Mar 2, 1984 | SESE |

## Top Applicants

- Aries Medical, Inc. — 1 clearance
- Meridian Diagnostics, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MJL](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MJL)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com